Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MGTX |
---|---|---|
09:32 ET | 1364 | 5.93 |
09:33 ET | 607 | 5.87 |
09:35 ET | 2200 | 5.83 |
09:37 ET | 2700 | 5.91 |
09:39 ET | 200 | 5.8275 |
09:42 ET | 600 | 5.885 |
09:44 ET | 300 | 5.8642 |
09:46 ET | 1500 | 5.88 |
09:53 ET | 900 | 5.965 |
10:02 ET | 1200 | 5.91 |
10:06 ET | 100 | 5.915 |
10:08 ET | 350 | 5.89 |
10:13 ET | 100 | 5.89 |
10:15 ET | 300 | 5.91 |
10:22 ET | 389 | 5.93 |
10:24 ET | 100 | 5.92 |
10:29 ET | 100 | 5.9 |
10:36 ET | 100 | 5.88 |
10:38 ET | 100 | 5.9 |
10:49 ET | 140 | 5.93 |
11:02 ET | 406 | 5.9295 |
11:09 ET | 204 | 5.94 |
11:14 ET | 146 | 5.95 |
11:20 ET | 200 | 5.98 |
11:30 ET | 101 | 5.985 |
11:32 ET | 100 | 5.98 |
11:34 ET | 215 | 5.985 |
11:38 ET | 100 | 5.98 |
11:39 ET | 223 | 5.99 |
11:41 ET | 785 | 5.96 |
11:50 ET | 100 | 5.97 |
11:52 ET | 3450 | 6.03 |
11:57 ET | 100 | 6.015 |
11:59 ET | 200 | 6.03 |
12:01 ET | 102 | 6.04 |
12:03 ET | 500 | 6.04 |
12:06 ET | 100 | 6.03 |
12:10 ET | 100 | 6.03 |
12:17 ET | 155 | 6.04 |
12:19 ET | 500 | 6.04 |
12:30 ET | 100 | 6.04 |
12:32 ET | 4846 | 6.04 |
12:33 ET | 200 | 6.04 |
12:35 ET | 200 | 6.01 |
12:44 ET | 100 | 5.99 |
12:48 ET | 2000 | 6 |
12:53 ET | 235 | 6 |
12:57 ET | 3400 | 6.015 |
01:00 ET | 100 | 6.015 |
01:04 ET | 400 | 6.02 |
01:06 ET | 1000 | 6.02 |
01:08 ET | 995 | 6.01 |
01:09 ET | 1200 | 6.02 |
01:11 ET | 1000 | 6.01 |
01:13 ET | 200 | 6.01 |
01:15 ET | 100 | 6.01 |
01:22 ET | 114 | 6.01 |
01:26 ET | 782 | 5.99 |
01:29 ET | 100 | 5.99 |
01:33 ET | 400 | 5.99 |
01:36 ET | 100 | 6 |
01:38 ET | 1731 | 6 |
01:40 ET | 1024 | 5.965 |
01:42 ET | 400 | 5.95 |
01:44 ET | 100 | 5.94 |
02:00 ET | 300 | 5.96 |
02:03 ET | 100 | 5.96 |
02:05 ET | 500 | 5.94 |
02:09 ET | 300 | 5.95 |
02:12 ET | 200 | 5.96 |
02:18 ET | 691 | 5.95 |
02:21 ET | 100 | 5.95 |
02:23 ET | 400 | 5.95 |
02:25 ET | 100 | 5.95 |
02:30 ET | 500 | 5.97 |
02:32 ET | 100 | 5.96 |
02:34 ET | 200 | 5.95 |
02:36 ET | 293 | 5.95 |
02:39 ET | 10231 | 5.9843 |
02:41 ET | 200 | 5.97 |
02:43 ET | 100 | 5.98 |
02:45 ET | 200 | 5.94 |
02:50 ET | 100 | 5.93 |
02:52 ET | 500 | 5.958 |
02:56 ET | 100 | 5.95 |
03:01 ET | 200 | 5.9537 |
03:06 ET | 2922 | 5.905 |
03:08 ET | 100 | 5.91 |
03:14 ET | 100 | 5.925 |
03:26 ET | 100 | 5.92 |
03:28 ET | 200 | 5.92 |
03:32 ET | 100 | 5.92 |
03:33 ET | 100 | 5.92 |
03:35 ET | 100 | 5.92 |
03:37 ET | 100 | 5.92 |
03:44 ET | 1640 | 5.89 |
03:46 ET | 100 | 5.89 |
03:48 ET | 300 | 5.89 |
03:50 ET | 100 | 5.89 |
03:51 ET | 499 | 5.89 |
03:53 ET | 1842 | 5.91 |
03:55 ET | 400 | 5.91 |
03:57 ET | 1712 | 5.92 |
04:00 ET | 39400 | 5.93 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
MeiraGTx Holdings PLC | 456.9M | -4.6x | --- |
Taysha Gene Therapies Inc | 446.8M | -39.5x | --- |
ProQR Therapeutics NV | 382.3M | -11.8x | --- |
4D Molecular Therapeutics Inc | 415.2M | -2.8x | --- |
Kalvista Pharmaceuticals Inc | 457.7M | -2.9x | --- |
Verve Therapeutics Inc | 389.5M | -2.0x | --- |
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage gene therapy company. The Company is focused on three distinct areas of unmet medical need: ocular diseases, including inherited retinal diseases (IRDs), as well as large degenerative ocular diseases, severe forms of xerostomia and neurodegenerative diseases. Its product pipeline includes botaretigene sparoparvovec or bota-vec, for the treatment of X-linked retinitis pigmentosa related to mutations in the retinitis pigmentosa GTPase regulator gene or XLRP-RPGR; AAV-hAQP1 for the treatment of radiation-induced Grade 2/3 Xerostomia; AAV-hAQP1 for the treatment of Sjogren’s Syndrome; AAV-GAD for the treatment of Parkinson’s Disease; AAV-RPE65 for the treatment of RPE65-asociated retinal dystrophy; AAV-CNGB3 and AAV-CNGA3 for the treatment of achromatopsia; AAV-AIPL1 for the treatment of LCA4, and AAV-RDH12 for the treatment of RDH12 mutation-associated retinal dystrophy.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $457.7M |
---|---|
Revenue (TTM) | $13.9M |
Shares Outstanding | 77.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.21 |
EPS | $-1.30 |
Book Value | $2.17 |
P/E Ratio | -4.6x |
Price/Sales (TTM) | 32.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,266.97% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.